Evidence map›Paper›PMID 27815424›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2016

Activating KIR2DS4 Is Expressed by Uterine NK Cells and Contributes to Successful Pregnancy.

Philippa R Kennedy, Olympe Chazara, Lucy Gardner, Martin A Ivarsson, Lydia E Farrell, Shiqiu Xiong, Susan E Hiby, Francesco Colucci, Andrew M Sharkey, Ashley Moffett

Open access · hybridAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 3 pooled it
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 3 syntheses or guidelines pooled it, 97 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Human CD56National science review · 2024
    Article
  13. Article
  14. Article
  15. Endometrial TGFβ signaling fosters early pregnancy development by remodeling the fetomaternal interface.American journal of reproductive immunology (New York, N.Y. : 1989) · 2023
    Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 3 countries.

Philippa R KennedyDepartment of Pathology, University of Cambridge, Cambridge CB2 1QP, United Kingdom; philippa.kennedy@manchester.ac.uk am485@cam.ac.uk.ORCID 0000-0003-0239-5440
Olympe ChazaraDepartment of Pathology, University of Cambridge, Cambridge CB2 1QP, United Kingdom.ORCID 0000-0003-0480-7808
Lucy GardnerDepartment of Pathology, University of Cambridge, Cambridge CB2 1QP, United Kingdom.ORCID 0000-0003-1735-2005
Martin A IvarssonDepartment of Pathology, University of Cambridge, Cambridge CB2 1QP, United Kingdom.ORCID 0000-0002-7745-1331
Lydia E FarrellDepartment of Pathology, University of Cambridge, Cambridge CB2 1QP, United Kingdom.ORCID 0000-0002-7643-6009
Shiqiu XiongDepartment of Pathology, University of Cambridge, Cambridge CB2 1QP, United Kingdom.ORCID 0000-0003-4056-8779
Susan E HibyDepartment of Pathology, University of Cambridge, Cambridge CB2 1QP, United Kingdom.
Francesco ColucciCentre for Trophoblast Research, University of Cambridge, Cambridge CB2 3EG, United Kingdom.ORCID 0000-0001-5193-6376
Andrew M SharkeyDepartment of Pathology, University of Cambridge, Cambridge CB2 1QP, United Kingdom.ORCID 0000-0002-5072-7748
Ashley MoffettDepartment of Pathology, University of Cambridge, Cambridge CB2 1QP, United Kingdom; philippa.kennedy@manchester.ac.uk am485@cam.ac.uk.ORCID 0000-0002-8388-9073
University of Cambridge · GBUniversity of Leicester · GB

Funding

British Heart Foundation PG/09/077/27964Wellcome Trust 085765Wellcome Trust 090108
6 · The paper itself

Abstract

Tissue-specific NK cells are abundant in the pregnant uterus and interact with invading placental trophoblast cells that transform the maternal arteries to increase the fetoplacental blood supply. Genetic case-control studies have implicated killer cell Ig-like receptor (KIR) genes and their HLA ligands in pregnancy disorders characterized by failure of trophoblast arterial transformation. Activating KIR2DS1 or KIR2DS5 (when located in the centromeric region as in Africans) lower the risk of disorders when there is a fetal HLA-C allele carrying a C2 epitope. In this study, we investigated another activating KIR, KIR2DS4, and provide genetic evidence for a similar effect when carried with KIR2DS1 KIR2DS4 is expressed by ∼45% of uterine NK (uNK) cells. Similarly to KIR2DS1, triggering of KIR2DS4 on uNK cells led to secretion of GM-CSF and other chemokines, known to promote placental trophoblast invasion. Additionally, XCL1 and CCL1, identified in a screen of 120 different cytokines, were consistently secreted upon activation of KIR2DS4 on uNK cells. Inhibitory KIR2DL5A, carried in linkage disequilibrium with KIR2DS1, is expressed by peripheral blood NK cells but not by uNK cells, highlighting the unique phenotype of uNK cells compared with peripheral blood NK cells. That KIR2DS4, KIR2DS1, and some alleles of KIR2DS5 contribute to successful pregnancy suggests that activation of uNK cells by KIR binding to HLA-C is a generic mechanism promoting trophoblast invasion into the decidua.

Indexed as

Cell LineDeciduaFemaleGene Expression RegulationGranulocyte-Macrophage Colony-Stimulating FactorHumansKiller Cells, NaturalPregnancyReceptors, KIRTrophoblastsGranulocyte-Macrophage Colony-Stimulating FactorKIR2DS1 protein, humanKIR2DS4 protein, humanKIR2DS5 protein, humanReceptors, KIR

Identifiers

PMID27815424
PMCPMC5114884
OpenAlexW2547855311

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.